MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.

Saved in:
Bibliographic Details
Title: MAP4K4 controlled integrin β1 activation and c-Met endocytosis are associated with invasive behavior of medulloblastoma cells.
Authors: Tripolitsioti D; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland., Kumar KS; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland., Neve A; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland., Migliavacca J; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland., Capdeville C; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland., Rushing EJ; Institute of Neuropathology, University Hospital Zürich, Zürich, Switzerland., Ma M; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland., Kijima N; Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Sharma A; Department of Radiation Oncology, University Hospital Zürich, Zürich, Switzerland., Pruschy M; Department of Radiation Oncology, University Hospital Zürich, Zürich, Switzerland., McComb S; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland., Taylor MD; Division of Neurosurgery, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada., Grotzer MA; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.; University Children's Hospital Zürich, Department of Oncology, Zürich, Switzerland., Baumgartner M; University Children's Hospital Zürich, Department of Oncology, Children's Research Center, Zürich, Switzerland.
Source: Oncotarget [Oncotarget] 2018 May 01; Vol. 9 (33), pp. 23220-23236. Date of Electronic Publication: 2018 May 01 (Print Publication: 2018).
Publication Type: Journal Article
Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1949-2553
DOI:10.18632/oncotarget.25294